BioCentury | Aug 15, 2020
Product Development

Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more

...based on data from the Phase II CD10...
BioCentury | Mar 21, 2018
Company News

Weather delay for achondroplasia meeting

...is a c-type natriuretic peptide (CNP; NPPC) analog resistant to neutral endopeptidase (neprilysin; MME; NEP; CD10...
BioCentury | Jan 25, 2018
Company News

Novartis gains ex-U.S. rights to Spark's gene therapy, and reports earnings

...type 1 (AT1) receptor (ATGR1); with sacubitril, an inhibitor of neutral endopeptidase (neprilysin; MME; NEP; CD10...
...$55.36 on Wednesday. Elizabeth S. Eaton Entresto Kymriah Luxturna Alcon Inc. Novartis AG Sandoz Ltd. Spark Therapeutics Inc. Angiotensin II type 1 (AT1) receptor (AGTR1) CD19 neprilysin Retinal...
BioCentury | Jul 18, 2017
Company News

Novartis mulls outcome-based price for CAR T therapy

...receptor (ATGR1), and sacubitril, an inhibitor of neutral endopeptidase ( neprilysin ; MME ; NEP; CD10...
BioCentury | Jun 22, 2017
Clinical News

Novartis' canakinumab cuts CV risk in MI patients

...$526.53 on Thursday. Jaime De Leon ACZ885 canakinumab Entresto Ilaris LCZ696 sacubitril/valsartan Novartis AG Regeneron Pharmaceuticals Inc. Angiotensin II type 1 (AT1) receptor (AGTR1) Interleukin-1 (IL-1) beta Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10)...
BioCentury | Apr 25, 2017
Company News

Novartis confident in 2017 Entresto goal

...neprilysin ; MME ; NEP; CD10). Chris Lieu Cosentyx Entresto serelaxin Novartis AG Angiotensin II type 1 (AT1) receptor (AGTR1) Interleukin-17A (IL-17A) Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10) Relaxin...
BioCentury | Jan 26, 2017
Company News

Novartis mulls Alcon options, reports earnings

...receptor (ATGR1), and sacubitril, an inhibitor of neutral endopeptidase ( neprilysin ; MME ; NEP; CD10...
...be flat to the low single digits. Chris Lieu Cosentyx crizanlizumab CTL019 Entresto Novartis AG Angiotensin II type 1 (AT1) receptor (AGTR1) CD19 Interleukin-17A (IL-17A) Membrane metallo-endopeptidase (MME) (NEP) (CD10) P...
BioCentury | Dec 14, 2016
Clinical News

Vosoritide: Ph III started

...CNP ; NPPC) analog resistant to neutral endopeptidase ( neprilysin ; MME ; NEP; CD10...
BioCentury | Oct 31, 2016
Clinical News

TD-0714: Phase I data

...Product: TD-0714 Business: Cardiovascular, Renal Molecular target: Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10) Description: Selective neutral endopeptidase (neprilysin; MME; NEP; CD10...
BioCentury | Jul 11, 2016
Company News

Eli Lilly, Novartis sales and marketing update

...receptor (ATGR1), and sacubitril, an inhibitor of neutral endopeptidase ( neprilysin ; MME ; NEP; CD10...
Items per page:
1 - 10 of 68